•  
• Tweet
•  
•  
•        Print
•  
•        Email
•  
•         Track Keywords

Ms. Gonzalo joins Oberland Capital from Vatera Healthcare Partners, the venture capital and private equity investing arm of Vatera Holdings LLC, where she was a Managing Director focused on investments in the biopharmaceutical industry. Previously, Ms. Gonzalo was a Managing Director with Essex Woodlands, a healthcare-focused growth equity firm. Ms. Gonzalo also worked in the healthcare group of Warburg Pincus LLC, a global private equity firm, and at Goldman, Sachs & Co. earlier in her career. Ms. Gonzalo earned an A.B. in Biochemical Sciences from Harvard College and an M.B.A. from Harvard Business School.

Mr. Bloom joined Oberland Capital in 2013 as the firm's first employee and has now been promoted from Principal to Partner. Prior to joining Oberland Capital, Mr. Bloom was a member of the investment team at Paul Capital in the firm's healthcare royalty platform. Prior to joining Paul Capital, Mr. Bloom worked at the Frankel Group, a healthcare-focused consulting firm. Mr. Bloom earned his M.B.A. with honors from the Wharton School's Healthcare Management Program and his B.A. from Colby College.

Oberland Capital also announced the hiring of CN Chen, Director of Quantitative Research, Daniel James, Director of Business Development and Investor Relations, and the further expansion of its investment team with the hiring of Sarah Siber, Vice President, and Greg Certo, Associate.